Experiences of cystic fibrosis newborn screening and genetic counseling

被引:0
|
作者
Kimberly Foil
Lillian Christon
Cheryl Kerrigan
Patrick A. Flume
Jaclyn Drinkwater
Sylvia Szentpetery
机构
[1] Medical University of South Carolina,Department of Medicine
[2] Medical University of South Carolina,Department Psychiatry and Behavioral Sciences
[3] Medical University of South Carolina,Department of Pediatrics
来源
Journal of Community Genetics | 2023年 / 14卷
关键词
Cystic fibrosis; Newborn screening; Genetic counseling; Parents; Distress; Comprehension;
D O I
暂无
中图分类号
学科分类号
摘要
The South Carolina cystic fibrosis (CF) newborn screening (NBS) program changed in 2019 to include CFTR genotyping for babies with top 4% immunoreactive trypsinogen, which improves sensitivity and timeliness but increases carrier detection. Carrier identification has genetic implications for the family and parents of NBS+ babies have increased emotional distress. Genetic counseling (GC) may increase parent understanding and reduce anxiety yet is not uniformly offered at CF centers. We report our early results after implementing GC for NBS+ families at the time of sweat chloride testing based on GC availability, which resulted in an unselected GC− control arm. Sixteen mothers (GC+ = 9, GC− = 7) participated in an online survey about their experience. Responses were analyzed in aggregate and for differences between GC+ and GC− groups. All-respondent sadness and anxiety increased with notification of the NBS+ result and decreased after sweat test results. Anxiety and sadness were greater in GC− compared to GC+ until after the diagnosis was resolved, though emotional differences between the groups were not statistically significant. On a scale of 0 = not at all to 10 = extremely, GC was rated very helpful (mean 9.0, range 5–10), informative (mean 8.9, range 4–10), comforting (mean 9.1, range 6–10), and minimally distracting (mean 1.8, range 0–9). All participants correctly identified that a risk for a child to have CF exists when both parents are (at least) carriers. Delivery of NBS results to respondents varied by timing, informant, and information given. The child’s pediatrician notified 10 (62.5%) of the NBS+ result. Parents felt they were notified in a timely manner (68.8%), by someone knowledgeable about NBS (62.5%), the sweat test (62.5%), CF (43.8%), and genetics (43.8%) and who cared about them (81.3%). Parents felt worried (81.3%), confused (81.3%), empowered (25%), and other (sad, shocked, scared, overwhelmed, devastated, defeated). Data from this single-center study suggest benefit of GC, that families would value earlier contact with an expert, and that prompt diagnostic resolution may reduce duration of parental distress.
引用
收藏
页码:621 / 626
页数:5
相关论文
共 50 条
  • [41] Parents’ experience with positive newborn screening results for cystic fibrosis
    Inken Brockow
    Uta Nennstiel
    European Journal of Pediatrics, 2019, 178 : 803 - 809
  • [42] FALSE NEGATIVE RESULTS ON NEWBORN SCREENING FOR CYSTIC-FIBROSIS
    HENRY, RL
    BOULTON, TJC
    RODDICK, LG
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1990, 26 (03) : 150 - 151
  • [43] Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening
    Collins, Melanie Sue
    Abbott, Mary-Alice
    Wakefield, Dorothy B.
    Lapin, Craig D.
    Drapeau, Ginny
    Hopfer, Sidney M.
    Greenstein, Robert M.
    Cloutier, Michelle M.
    PEDIATRIC PULMONOLOGY, 2008, 43 (07) : 648 - 655
  • [44] A survey of newborn screening for cystic fibrosis in Europe
    Southern, Kevin W.
    Munck, Anne
    Pollitt, Rodney
    Travert, Georges
    Zanolla, Luisa
    Dankert-Roelse, Jeannette
    Castellani, Carlo
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (01) : 57 - 65
  • [45] Clinical outcomes of newborn screening for cystic fibrosis
    Waters, DL
    Wilcken, B
    Irwig, L
    Van Asperen, P
    Mellis, C
    Simpson, JM
    Brown, J
    Gaskin, KJ
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1999, 80 (01): : F1 - F7
  • [46] Genetic counseling for cystic fibrosis: A basic model with new challenges
    Bieth, E.
    Nectoux, J.
    Girardet, A.
    Gruchy, N.
    Mittre, H.
    Laurans, M.
    Guenet, D.
    Brouard, J.
    Gerard, M.
    ARCHIVES DE PEDIATRIE, 2020, 27 : ES30 - ES34
  • [47] Refinement of newborn screening for cystic fibrosis with next generation sequencing
    Rock, Michael J. J.
    Baker, Mei
    Antos, Nicholas
    Farrell, Philip M. M.
    PEDIATRIC PULMONOLOGY, 2023, 58 (03) : 778 - 787
  • [48] Cost effectiveness of newborn screening for cystic fibrosis: A simulation study
    Nshimyumukiza, L.
    Bois, A.
    Daigneault, P.
    Lands, L.
    Laberge, A. -M.
    Fournier, D.
    Duplantie, J.
    Giguere, Y.
    Gekas, J.
    Gagne, C.
    Rousseau, F.
    Reinharz, D.
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (03) : 267 - 274
  • [49] Vitamin D in infants with cystic fibrosis diagnosed by newborn screening
    Neville, Liza A.
    Ranganathan, Sarath C.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2009, 45 (1-2) : 36 - 41
  • [50] Kids in America: Newborn Screening for Cystic Fibrosis
    Bender, Laura M.
    Cotten, Steven W.
    Willis, Monte S.
    LABMEDICINE, 2011, 42 (10): : 595 - 601